MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0236308
Rydan Pharmaceuticals Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.11 Cr
▲ 24% YoY
Net profit · FY 2025
₹1.42 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹1.7 Lakh
EBITDA margin 1.5%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹39.9 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Rydan Pharmaceuticals Private Limited
Data last updated:
Rydan Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24299RJ2019PTC065317. Its GSTIN is 08AAJCR6539D1Z6 (Rajasthan).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹39.9 Lakh. It is led by directors including Jyoti Shekhawat and Preeti Agarwal.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.42 Lakh (net margin 1.3%) and EBITDA of ₹1.7 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 63% over five years.
Rydan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0236308). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rydanpharmaceuticals.com.
Company Details of Rydan Pharmaceuticals Private Limited
CIN U24299RJ2019PTC065317
Registration Number 065317
Incorporation Date 14 June 2019
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0236308
Recognitions & Rankings of Rydan Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. – 18 Basement Naman Plaza, Parbasi Nagar Kedia Palace Crossing, Jaipur, Rajasthan, India – 302039
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Rydan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Rydan Pharmaceuticals Private Limited
The main business activity of Rydan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rydan Pharmaceuticals Private Limited FY 2025 filings available
Rydan Pharmaceuticals Private Limited reported revenue of ₹1.11 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹1.11 Cr ▲ 24%
Net profit · FY 2025
₹1.42 Lakh margin 1.3%
EBITDA · FY 2025
₹1.7 Lakh margin 1.5%
Compounded Annual Growth Rate (CAGR) of Rydan Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 38%
5 years · compounded
▲ 63%
EBITDA CAGR growth
1 year
▲ 239%
3 years · compounded
▲ 39%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 63% over five years, including 24% growth in the latest year. EBITDA rose 239% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rydan Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.42 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rydan Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rydan Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Shekhawat | Director | 14 Jun 2019 | 7 Years 4 Months | Current |
| Preeti Agarwal Also directs: Varansutraa LLP, Meena Agarwal Welfare Foundation | Director | 18 Oct 2019 | 7 Years 0 Months | Current |
| Alka Kanoji | Director | 18 Oct 2019 | 7 Years 0 Months | Current |
| Ankur Goyal Also directs: Krident Surgicals Private Limited | Director | 14 Jun 2019 | 7 Years 4 Months | Current |
Peer Comparison of Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nikhi Health Care Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Davanagere, Karnataka, India |
| Quantrix Healthcare Private Limited | ₹1.11 Cr (FY 2020) | •••• | •••• | -34.0% | •••• | Indore, Madhya Pradesh, India |
| New Search Life Sciences Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Radmex Healthcare Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 1258.0% | •••• | New Delhi, Delhi, India |
| Saudavel Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Margao, Goa, India |
| Rydan Pharmaceuticals Private Limited this company | ₹1.11 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Jaipur, Rajasthan, India |
| Sreeha Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2021) | •••• | •••• | 752.0% | •••• | Hyderabad, Telangana, India |
| Avsan Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | •••• | •••• | 703.0% | •••• | Delhi, India |
| Macway Biotech Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Hyderabad, Telangana, India |
| Aphali Pharmaceuticals Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Medcutis Biotech Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Nanded, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Rydan Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals Private Limited is audited by MODI V & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MODI V & COMPANY | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rydan Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rydan Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Rydan Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals Private Limited has 8 board changes on record since 2019: 4 appointments and 4 cessations. The latest: Ghan Shyam Sharma ceased to be Director on 08 Mar 2021.
AGM
Rydan Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records.
Filing
Rydan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Ceased
Ghan Shyam Sharma ceased to be Director.
Ceased
Alka Kanoji ceased to be Additional Director.
Ceased
Preeti Agarwal ceased to be Additional Director.
Appointed
Alka Kanoji was appointed as Director.
Ceased
Diwakar Agarwal ceased to be Director.
Appointed
Preeti Agarwal was appointed as Director.
Appointed
Ankur Goyal was appointed as Director.
Appointed
Jyoti Shekhawat was appointed as Director.
Incorporation
14 Jun 2019
Rydan Pharmaceuticals Private Limited was registered on 14 Jun 2019 with Roc Jaipur & aged 7 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Rydan Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rydan Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rydan Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAJCR6539D1Z6 | Rajasthan | Active | 16 Aug 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rydan Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rydan Pharmaceuticals Private Limited
Rydan Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 2019 (7+ years old) and is registered under CIN U24299RJ2019PTC065317.
Rydan Pharmaceuticals reported revenue of ₹1.11 Cr for FY 2025 (up 24% YoY).
Rydan Pharmaceuticals has 4 current directors:
- Jyoti Shekhawat - Director
- Preeti Agarwal - Director
- Alka Kanoji - Director
- Ankur Goyal - Director
Rydan Pharmaceuticals reported a net profit of ₹1.42 Lakh (net margin 1.3%) and EBITDA of ₹1.7 Lakh (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rydan Pharmaceuticals is 38% over three years and 63% over five years. In the latest year (FY 2025) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rydan Pharmaceuticals is 08AAJCR6539D1Z6, registered in Rajasthan.
The CIN (Corporate Identification Number) of Rydan Pharmaceuticals is U24299RJ2019PTC065317. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rydan Pharmaceuticals was incorporated on 14 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Rydan Pharmaceuticals by revenue are Nikhi Health Care Private Limited, Quantrix Healthcare Private Limited, New Search Life Sciences Private Limited, Radmex Healthcare Private Limited, Saudavel Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ghan Shyam Sharma ceased to be Director on 08 Mar 2021. Alka Kanoji ceased to be Additional Director on 31 Dec 2020. Preeti Agarwal ceased to be Additional Director on 31 Dec 2020. Rydan Pharmaceuticals has 8 board changes on record in total.
Yes, Rydan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0236308).